Skip to content

RNTX RNTX Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

CalAmp logo
CalAmpCAMP
$0-100%
Centerspace logo
CenterspaceCSR
$43K-93.9%
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
$0
Empire State Realty Trust logo
Empire State Realty TrustESRT
$5.99M+278%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$28.57M
Blaize Holdings, Inc. Common Stock logo
Blaize Holdings, Inc. Common StockBZAI
$0-100%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: RNTX’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's exchange offer (note 12)?
RNTX (RNTX) reported exchange offer (note 12) of $0 in Q4 2025.
What does exchange offer (note 12) mean?
This metric quantifies the value of securities converted into common stock, such as the exchange of debt or preferred equity for common shares. It highlights significant shifts in the capital structure and the dilution of existing shareholders resulting from these conversion events. Tracking this is essential for understanding changes in equity composition and the company's strategy for managing its capital stack.